Target intelligence / Profile preview

MicroRNA 3942 (miR-3942 (MIR3942))

Target
miR-3942 (MIR3942)
Molecular classification
microRNA, non-coding RNA, Small regulatory RNA
01

Overview

MicroRNA 3942 (miR-3942) is a human microRNA (miRNA), a small non-coding RNA molecule—typically 20-24 nucleotides—that regulates gene expression post-transcriptionally, either by promoting mRNA degradation or repressing translation by partially binding to the 3' untranslated region of target mRNAs[1][2]. miRNAs are essential regulators in many biological processes including cell proliferation, differentiation, and apoptosis, and are implicated in many disease states such as cancer and neurodegeneration[5][6]. However, as of September 2025, microRNA 3942 itself has no well-characterized molecular targets, disease roles, or known therapeutic relevance in the published scientific literature, and it is neither established as a therapeutic target nor used as a biomarker or pharmacological target. Additionally, the molecule’s nomenclature appears somewhat inconsistent across minor sources (“hsa-mir-3942,” “miR-3942-5p”), but this does not materially affect its status and does not represent a significant error. Current absence of functional, disease, or drug-specific data makes this entry incomplete for therapeutic or clinical target annotation.

Other names
miR-3942MIR3942hsa-mir-3942hsa-mir-3942-5p
02

Mechanism of action

Not applicable; there are no drugs that directly target microRNA 3942. General microRNA mechanisms include inhibition of translation and mRNA degradation[1][2].

03

Biological functions

Post-transcriptional regulation of gene expression[1][2]mRNA degradation or translation inhibition[1][2]Possible involvement in cell-type and tissue-specific regulatory processes[2]Possible involvement in RNA silencing[1]
04

Disease associations

No known direct disease association is reported for microRNA 3942 specifically in verified literature.General microRNA roles include involvement in cancer[5], neurodegenerative diseases[6], and cardiovascular diseases[1], but microRNA 3942 itself is not explicitly linked.
05

Safety considerations

None reported specifically for microRNA 3942.
06

Interacting drugs

No drugs known to interact specifically with microRNA 3942.
07

Biomarkers

No reported biomarker use for microRNA 3942.

Beyond the preview

Go deeper on MicroRNA 3942 (miR-3942 (MIR3942)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 3942 (miR-3942 (MIR3942)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call